CAPR vs NVR · $1.62B cap vs P/E 15, rev $4.21B
Capricor Therapeutics Inc (CAPR) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
CAPR currently screens at market cap $1.62B. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the CAPR and NVR stock pages for the full models.
Not investment advice.